Penny Stock Runners – LIGHTSTREAM, (LSTMF),LONESTAR RESOURCES, (LNREF),Nuvilex, (OTCQB:NVLX),FORTUNE OIL & GAS, (OTCMKTS:FOGC)

Submitted By on July 01, 2014 - 06:20 PM

Stamford, Connecticut – 01 July, 2014 – (Techsonian) – LIGHTSTREAM, (OTCMKTS:LSTMF), is involved in the exploration and development of oil and natural gas in Western Canada. The company’s principal operating areas include the Bakken formation and conventional Mississippian reservoirs in southeastern Saskatchewan; the Cardium formation in Central Alberta; and the Swan Hills formation in north-central Alberta. It also explores for light oil resource plays.

LIGHTSTREAM RES (OTCMKTS:LSTMF) increased 0.65% at the price of $7.70 recently on a traded volume of 30,097 shares, in comparison to 89,077 shares of average trading volume. The company has a total market capitalization of $1.53 billion.

Will LSTMF Continue To Move Higher? Find Out Here

LONESTAR RESOURCES, (OTCMKTS:LNREF), an independent oil and gas company, obtains, explores for, develops, and produces oil and gas properties in the United States. The company first and foremost focuses on its Beall Ranch, Asherton, and Gonzo properties in the Eagle Ford Shale in South Texas; and holds a 65.0% working interest in the West Poplar asset that covers an area of 32,625 net acres in the Bakken and Three Forks plays in the Roosevelt County, Montana. Lonestar Resources Limited is headquartered in Fort Worth, Texas.

 

LONESTAR RESOURCES (OTCMKTS:LNREF) soared 11.11% at the trading price of $0.470 on a traded volume of 1.02 million shares till now, whereas its average trading volume is 1.13 million shares. The Intra-day range for the stock is $0.44 and $0.59. The company has a total market capitalization of $294.91 million.

For How Long LNREF will Fight for Profitability? Read This Trend Analysis report

Nuvilex, (OTCQB:NVLX), can accomplish more in its upcoming preclinical trials than many may realize. With the declaration that Translational Drug Development will be conducting the preclinical studies and clinical trials that will follow to study the Maryland biotech’s pancreatic cancer treatment and its ability to relieve symptoms associated with the deadly cancer, Nuvilex entered into a high profile opportunity.

Nuvilex Inc (OTCMKTS:NVLX) dropped down -0.89% at the $0.256 recently. The 52-week range for the stock is $0.02 and $0.62. Its introductory price for the day was $0.26, with the overall traded volume of 304,118 shares.

Has NVLX Found The Bottom And Ready To Gain Momentum? Find Out Here

FORTUNE OIL & GAS, (OTCMKTS:FOGC), reported that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved.

FORTUNE OIL & GAS IN (OTCMKTS:FOGC) after opening its shares at the price of $0.0009, dropped -11.11%, its recent trading price was $0.0008 for the day. The stock moved on a traded volume of 66.3 million shares, in comparison to 140.70 million shares of average trading volume.

The 52-week range for the stock is $0.0001 and $0.0018.

Will FOGC Get Buyers Even After The Recent Rally? Find Out Here